no key · no human

Biotech Insider API, RSS and sitemap

Every article Biotech Insider publishes, as JSON, through an open API with no key and no signup. 255 of their articles are indexed right now, refreshed hourly.

English#7,570 by volume

Four ways to pull biotech-insider.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from biotech-insider.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=biotech-insider.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=biotech-insider.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=biotech-insider.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=biotech-insider.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 60%economy 30%business 10%

Call the API

A live request. Paste it into a terminal and Biotech Insider headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=biotech-insider.com&size=5"
255
articles indexed
255
in the last 30 days
16
median per day
1
languages
1321 min
median crawl lag
21.08 → 06.09
archive depth

Publishing volume

Articles per day over the last 17 days. The busiest hour is 13:00 UTC — that is when the newsroom pushes its main batch.

2026-08-21: 3 articles2026-08-22: 10 articles2026-08-23: 8 articles2026-08-24: 9 articles2026-08-25: 12 articles2026-08-26: 20 articles2026-08-27: 20 articles2026-08-28: 20 articles2026-08-29: 20 articles2026-08-30: 16 articles2026-08-31: 10 articles2026-09-01: 16 articles2026-09-02: 18 articles2026-09-03: 20 articles2026-09-04: 20 articles2026-09-05: 20 articles2026-09-06: 13 articles08-2108-2308-2508-2708-2908-3109-0209-0409-06
bash
curl "https://freenewsapi.ai/v1/stats?host=biotech-insider.com&top=10"

Publishing rhythm

When Biotech Insider actually publishes, by hour of day (UTC) and by day of week — measured from 255 timestamps, not from a schedule they advertise.

00: 250001: 00102: 00203: 00304: 00405: 00506: 00607: 00708: 00809: 00910: 01011: 01112: 281213: 451314: 11415: 271516: 271617: 241718: 271819: 01920: 262021: 252122: 02223: 023
Mon: 19MonTue: 28TueWed: 38WedThu: 40ThuFri: 43FriSat: 50SatSun: 37Sun

Sections

Sections come from the publisher's own markup, present on 20% of their articles.

SectionArticles
economy51
health51

Languages

CodeLanguageArticlesShare
enEnglish255100.0%

Latest articles

The 18 most recent Biotech Insider articles in the index — the same rows the API returns, rendered for humans.

Typewriter Lands $56M to Put Jumping Genes to Work In Vivo
2026-09-06 20:05 UTC
Typewriter's $56 million round backs transposons — mobile genetic elements — as a way to insert whole genes without viral vectors or CRISPR, aimed first at CAR-T made ins
Novartis Commits Up to $3.2 Billion to Alteogen's Injection Tech
2026-09-06 18:56 UTC
Novartis becomes the third large drugmaker this year, after Biogen and GSK, to buy access to Alteogen's subcutaneous delivery platform, in a deal worth up to $3.2 billion
Moderna's Melanoma Jolt Puts Pharvaris and AbbVie in Frame
2026-09-06 13:36 UTC
A melanoma data setup at Moderna, a Phase 3 catalyst at Pharvaris and 13 years of dividend hikes at AbbVie mark three very different clocks in one healthcare trade.
Ultragenyx's Angelman Antisense Drug Misses in Phase 3
2026-09-06 12:52 UTC
Ultragenyx's antisense oligonucleotide for Angelman syndrome missed in Phase 3, removing a late-stage rare-disease asset and resetting expectations across competing progr
Ultragenyx Angelman Failure Turns an Approval Year Into Cost Cuts
2026-09-06 00:24 UTC
A phase 3 miss in Angelman syndrome has pushed Ultragenyx into cost-cutting mode just as its newly approved drug Genglycos reaches the market. What the failure changes.
Abivax Stays Single While Biotech M&A Runs Hot
2026-09-05 17:44 UTC
Biotech dealmaking is running hot, yet France's Abivax remains independent. Valuation, the timing of obefazimod data and its own financing options all point to why the ph
Cityblock's $116 Million Raise Fits Digital Health's Megaround Habit
2026-09-05 16:41 UTC
Cityblock's $116 million August financing is the newest data point in a year-long shift: digital health dollars are pooling into a shrinking set of very large private rou

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=biotech-insider.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=biotech-insider.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well Biotech Insider marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
20%
articles with sections
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 1321 min at the median, 6079 minutes at the 90th percentile.

Similar publishers

Comparable outlets in the same language. Those without a page here yet link straight to their slice of the API.

FAQ

Does Biotech Insider have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 255 of their articles and lets you filter by date, language and section.

How many articles does Biotech Insider publish per day?

16 on a median day, measured across 17 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.